James N. Topper
Director, La Jolla Pharmaceutical Company.
Companies
- AtentoBoard member Aug 4, 2026 to now1
- NewAmsterdam Pharma Co N.V.Board member Dec 29, 2023 to now2
- Phathom Pharmaceuticals, Inc.Board member Oct 24, 2019 to now3
- Alpine Immune SciencesBoard member Jul 26, 2017 to May 20, 20244
- ANAPTYSBIO, INCBoard member Jan 25, 2017 to Jan 10, 20235
- Frazier Lifesciences Acquisition CorpBoard member Dec 8, 2020 to Dec 17, 20206
- Frazier Lifesciences Acquisition CorpChief executive officer Dec 8, 2020 to Dec 17, 20206
- Allena Pharmaceuticals, Inc.Board member Nov 1, 2017 to Nov 18, 20207
- Aptinyx Inc.Board member Jun 20, 2018 to Apr 2, 20208
- Entasis TherapeuticsBoard member Sep 25, 2018 to Jan 22, 20199
- Sierra Oncology, Inc.Board member Jul 15, 2015 to Feb 16, 201710
- Amicus TherapeuticsBoard member May 30, 2007 to Jun 16, 201411
- La Jolla Pharmaceutical CompanyBoard member Feb 14, 2006 to Feb 26, 200912
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAtento, Board member
- 2
- 3
- 4SEC EDGARAlpine Immune Sciences, Board member
- 5SEC EDGARANAPTYSBIO, INC, Board member
- 6
- 7
- 8SEC EDGARAptinyx Inc., Board member
- 9SEC EDGAREntasis Therapeutics, Board member
- 10SEC EDGARSierra Oncology, Inc., Board member
- 11SEC EDGARAmicus Therapeutics, Board member
- 12